What does omnichannel mean in Pharma? And what does digital disruption mean for this increasingly complex industry?
Omnichannel Pharma does not exist in a vacuum. Many industries launched large-scale omnichannel transformations years ago, and consumers are experiencing the benefits. Digitization has been gradually occurring for many years with the percentage of customers who are willing to purchase digitally gradually increasing.
This naturally varies depending on the complexity of the product and the maturity of the market. Banking, for example, has seen widespread adoption of digital service channels.
Pharmaceutical and healthcare companies have been lagging behind other industries in providing an omnichannel experience since face-to-face communications are beneficial as part of service delivery. Although most businesses have begun to increase online services, many consumers still use traditional channels when interacting with them, for a variety of reasons.
Pharma and healthcare marketing notoriously relies on complex customer journeys. This has never been the case more than now, with increasing customer expectations of omnichannel decision-making.
What is omnichannel marketing?
At Smart Insights, we define omnichannel marketing to include both managing customer
experience and marketing communications:
“Planning and optimizing always-on and campaign-focused marketing communications tools across different customer lifecycle touchpoints to maximise leads and sales – all the while delivering a seamless customer experience to encourage customer loyalty”.
The number of online and offline channels that need to be orchestrated is shown by the RACE customer lifecycle visual featured in the introduction.
The challenge of omnichannel
“Omnichannel marketing is about providing appropriate and relevant content across different channels that ties together to create a unified message, without becoming repetitive.
Many companies try but fail to build an omnichannel experience for every channel and customer. Leaders should instead limit their focus to the top two or three cross-channel customer interactions.”
– McKinsey July 2020
Omnichannel Pharma, healthcare and medical marketing
Marketing leaders within the Pharma, healthcare, medical, and all patient-facing and medical-professional-facing marketing sectors have seen first-hand the effects of digital disruption on business as usual.
Viseven describes the movement from multichannel to omnichannel within healthcare as a
process that results in the connection of all channels through the customer journey as shown in this diagram.
Transcending the traditional B2B, B2C, and D2C business models, patients and medical buyers are clearly navigating very complex customer journeys.
Our RACE Framework helps marketing leaders strategize their marketing funnels to make the most of opportunities to attract and retain high-value customers at each stage of their decision-making journey.
Our popular 5-step strategy of plan, reach, act, convert, and engage gives marketers and managers a simple, streamlined structure for data-driven goal-setting, and optimizing their marketing activities to achieve the results they need.
Moreover, we have bespoke resources tailored to the individual challenges and opportunities for marketers in the pharma/healthcare industry, find out more.
The benefits of omnichannel Pharma marketing
One of the key drivers for the shift to omnichannel marketing activities is the recognition of the benefits to be had from adopting a patient-centred approach. This has been met with scepticism in its ability to drive actual business growth.
To understand this better, The Aurora Project, a global benchmark survey comprising 2,346 pharma industry respondents from 84 countries identified five key activities to take patient-focus and profitability to the next level.
- Engage patients: While some respondents believe pharma is doing enough to engage patients, others feel more needs to be done. Specifically, patients bring unique insights based on their experience with a drug and its current therapeutic environment. They can highlight areas of unmet need that clinicians may have underestimated.
- Budget/resources: An appropriate budget to act on patient-focused ideas is vital with a focus on early investment in patient engagement and interaction. In the long run, spending money on those things that help patients in the short and long-term DOES lead to better business results as prevention measures or vaccinations do in real health care.
- Measurement: It was felt that the power of big data can be harnessed to assess whether patient adherence and treatment persistence have improved in order to develop more direct relationships with patients and is an area with room for significant improvement.
- Training: Something to keep in mind is that every mistake from any company will affect trust in pharma as a whole – and thereby limit the possible success for all others. For this reason alone it is important that sufficient training is given to employees on how to behave in a patient-focused manner. Ultimately, pharma can’t afford to make mistakes that might reduce patient trust and,
therefore, better training in patient focus is fundamental.
- Focus across all departments: The general consensus is that everyone should be doing their part to engage in patient-focused efforts, thus embedding patient focus across an entire company. It is only through the integration of different functional expertise and methods can you gain a comprehensive patient understanding and approach.
When looking at each business or experience metric you can see the interdependencies that exist. Being patient-centric is necessary for companies that truly believe in the concept of making a positive impact in the lives of their customers. Business growth will happen because of it. By taking into account patient opinions on key decisions companies are able to build strong connections.
One example is the voice of the patient, which is a game-changer in pharma, from product development, regulatory approval, and commercialization. Customer needs evolve over time and it is our duty to remain relevant. The current pandemic has taught us how quickly we sometimes need to adapt, reinvent and be there with our customers.
What is an omnichannel plan?
We recommend planning your pharma/healthcare marketing communications using the RACE Framework. This integrated step-by-step framework helps marketers and managers plan their digital media and experiences across the customer lifecycle of reach, act, convert, and engage.
1,000s of Smart Insights Business Members are already using the RACE Framework and integrated tools and templates to plan omnichannel marketing strategies for their businesses.
Recommended heathcare and pharma marketing channels
The growth in social channels such as Snapchat, Instagram and TikTok may seem like an ocean of opportunity. However, in Europe, many of these channels are too risky or inappropriate for pharma communications given the potential for reputational damage and because of the risk of industry guidelines.
For example, UK Prescription Medicines Code of Practice Authority (PMCPA) guidance should be followed and the cases brought under PMCPA highlight the type of breaches that can occur in ads or within consumer sites. For example, an ad by Vifor Pharma was ruled in breach of the following clauses of the Code:
- Clause 2 – Bringing discredit upon, and reducing confidence in, the pharmaceutical industry
- Clause 7.2 – Making misleading and inaccurate claims
- Clause 7.3 – Making misleading comparisons
- Clause 8.1 – Disparaging a competitor product
Historically, pharma’s channel tactics tend to be more conventional. The Multichannel
Maturometer from Across Health reveals the most widely-used tactics include:
- eDetailing (84%)
- pharma-owned websites (71%)
- direct marketing (58%) and email marketing (57%)
- web banners (52%)
- web conferences (41%)
- online medical education (40%)
- HCP self-service portals (36%).
Activities such as marketing automation, adherence tools, social media monitoring/ marketing, and quantified self/self-tracking devices are a long way from becoming standard practice but they are increasing.
The reality is that although channels and opportunities are growing in number, it’s neither
possible nor sensible to invest in everything. Success requires understanding the right channels for a particular audience and integrating them to create a consistent experience across them all.
Optimize your Pharma marketing strategy to benefit from Omnichannel
To summarise, the principle at the heart of understanding the difference between multichannel and omnichannel Pharma is to be selective. The goal should be to use ‘many’ channels (multichannel), but in such a way that there is a seamless experience across the most appropriate channels for your customers (omnichannel).
Without an Omnichannel mindset, you may be missing out on crucial opportunities to improve your brand experience across all channels, at every stage of the buying funnel.
We’ve got marketing tools, templates, and training designed to help Pharma and healthcare marketers make the best decisions for their businesses, and inform their marketing strategies to win more customers. Find out how your company could benefit from Smart Insights Business Membership.